Literature DB >> 17937622

B- and T-cell-specific inactivation of thioredoxin reductase 2 does not impair lymphocyte development and maintenance.

Roland Geisberger1, Claudia Kiermayer, Cornelia Hömig, Marcus Conrad, Jörg Schmidt, Ursula Zimber-Strobl, Markus Brielmeier.   

Abstract

Thioredoxin reductases (Txnrds) are a group of selenoenzymes participating in cellular redox regulation. Three Txnrd isoforms are known, each of which exhibits distinct cellular localisation and tissue-specific expression pattern. Txnrd1 is found in the cytoplasm, expression of Txnrd2 is restricted to mitochondria and Txnrd3 shows testis-specific expression. Recently, it was shown that Txnrd2 strongly affects the development of blood cells, since mouse embryos deficient for Txnrd2 are severely anaemic, show increased apoptosis in foetal liver and possess haematopoietic liver stem cells of reduced capacity to proliferate in vitro. However, because Txnrd2-deficient mice die at embryonic day 13.5, it was not known how this enzyme affects blood cell function in the adult animal. In the present study we show that conditional Txnrd2 knockouts generated using CD4- and CD19Cre transgenic mice lack Txnrd2 expression in CD4-- and CD19-positive T- and B-lymphocytes, respectively. However, the development and differentiation of both cell types in thymus and bone marrow was not significantly impaired. In addition, B-cell proliferation and activation in response to CD40 and IL-4 was unaltered in Txnrd2-deficient B-cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17937622     DOI: 10.1515/BC.2007.131

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  10 in total

Review 1.  Understanding selenoprotein function and regulation through the use of rodent models.

Authors:  Marina V Kasaikina; Dolph L Hatfield; Vadim N Gladyshev
Journal:  Biochim Biophys Acta       Date:  2012-03-13

Review 2.  The A to Z of modulated cell patterning by mammalian thioredoxin reductases.

Authors:  Markus Dagnell; Edward E Schmidt; Elias S J Arnér
Journal:  Free Radic Biol Med       Date:  2017-12-24       Impact factor: 7.376

Review 3.  Redox regulation of immunometabolism.

Authors:  Jonathan Muri; Manfred Kopf
Journal:  Nat Rev Immunol       Date:  2020-12-18       Impact factor: 53.106

Review 4.  Paradoxical Roles of Antioxidant Enzymes: Basic Mechanisms and Health Implications.

Authors:  Xin Gen Lei; Jian-Hong Zhu; Wen-Hsing Cheng; Yongping Bao; Ye-Shih Ho; Amit R Reddi; Arne Holmgren; Elias S J Arnér
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

Review 5.  The human selenoproteome: recent insights into functions and regulation.

Authors:  M A Reeves; P R Hoffmann
Journal:  Cell Mol Life Sci       Date:  2009-04-28       Impact factor: 9.261

Review 6.  In the line-up: deleted genes associated with DiGeorge/22q11.2 deletion syndrome: are they all suspects?

Authors:  Zahra Motahari; Sally Ann Moody; Thomas Michael Maynard; Anthony-Samuel LaMantia
Journal:  J Neurodev Disord       Date:  2019-06-07       Impact factor: 4.025

7.  Selenium Nanoparticles Induce Potent Protective Immune Responses against Vibrio cholerae WC Vaccine in a Mouse Model.

Authors:  Zahra Raahati; Bita Bakhshi; Shahin Najar-Peerayeh
Journal:  J Immunol Res       Date:  2020-12-30       Impact factor: 4.818

8.  Selenoproteins as regulators of T cell proliferation, differentiation, and metabolism.

Authors:  Chi Ma; Peter R Hoffmann
Journal:  Semin Cell Dev Biol       Date:  2020-11-17       Impact factor: 7.499

9.  The thioredoxin-1 system is essential for fueling DNA synthesis during T-cell metabolic reprogramming and proliferation.

Authors:  Jonathan Muri; Sebastian Heer; Mai Matsushita; Lea Pohlmeier; Luigi Tortola; Tobias Fuhrer; Marcus Conrad; Nicola Zamboni; Jan Kisielow; Manfred Kopf
Journal:  Nat Commun       Date:  2018-05-10       Impact factor: 14.919

Review 10.  Selenium, Selenoproteins, and Immunity.

Authors:  Joseph C Avery; Peter R Hoffmann
Journal:  Nutrients       Date:  2018-09-01       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.